Nektar Therapeutics
0UNL.L
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the t...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-07-18
Stock Exchange
LSE
Ticker
0UNL.L
PE Ratio
[-21.11]
ROE
[-356.81%]
Current Ratio
[4.24]
Dividend Yield
[0%]
Enterprise Value
[1.16B]
Dividend History
0UNL.L Dividend History Overview
Dividends are a key part of long-term returns for investors, and Nektar Therapeutics (0UNL.L) has a track record worth reviewing. Looking at dividend history for 0UNL.L gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2022-03-15
Dividend Yield
0%
Annual Dividend
$0.02
P/E Ratio
-21.11
Payout Ratio
0
Dividend per Share
$0
EPS
-2.66
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2022-03-15 | $0.019 | $0.285 |
Nektar Therapeutics (0UNL.L) Dividend History Chart
The table below shows Nektar Therapeutics (0UNL.L) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Nektar Therapeutics (0UNL.L) Dividend Growth
Nektar Therapeutics (0UNL.L) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Nektar Therapeutics (0UNL.L) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is 0UNL.L’s dividend yield?
What is the difference between regular and special dividends?
Has 0UNL.L increased its dividends over time?
Why might dividend history data be delayed?
How often does 0UNL.L pay dividends?
What factors impact 0UNL.L's dividend payments?
Can dividends change over time?
What is 0UNL.L’s next dividend date?